Amgen, Inc. ( NASDAQ: AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call February 12, 2025 11:20 AM ET Narimon Honarpour - Senior Vice President, Global Development Justin Claeys - ...

As with Epogen, the initial discoveries that laid the basis for the drug had ... That decade of investment and research was paying off. In 1992, Amgen hit the billion dollars sales mark and ...

Story Feb. 13 - Encoded Therapeutics: The gene therapy biotech is laying off 29% of staffers as it focuses ... by 40% and reassessing the future of Amgen-partnered T-cell engager CX-904 as a ...

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Presentation Operator Good morning, and welcome to the Interpublic Group 4th-Quarter and Full-Year 2024 Conference Call. All ...

Readers hoping to buy Amgen Inc. ( NASDAQ:AMGN ) for its dividend will need to make their move shortly, as the stock ...

Biotechnology company, Amgen, has announced that it has entered into a definitive agreement to acquire deCODE Genetics, a global leader in human genetics, for US $415 million. The all-cash ...

At least 1,100 employees were laid off. The reasons for the layoffs were that Blue Origin grew and hired fast over the years, ...

Jeff Bezos' aerospace company, Blue Origin, is laying off about 1,000 workers, according to media reports. Blue Origin CEO ...

Jeff Bezos's space company Blue Origin announced on Thursday it will be laying off 10% of its staff less than a month after ...

Blue Origin has announced plans to lay off about 10% of its workforce — or more than 1,000 employees — nearly a month after ...

Blue Origin announces layoffs affecting over 1,000 employees weeks after launching its first orbital rocket, New Glenn.